VAERS reports by lot

Moderna COVID-19 lot AS1416B: VAERS reports

182 VAERS reports list lot AS1416B as a Moderna COVID-19 vaccine, received between 2022-06-21 and 2023-08-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
182
Reports
3%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Dermatological (non-injection-site)5017%
General / Systemic (non-local)5017%
Injection-site / Local reaction4515%
Gastrointestinal4315%
Neurological238%
Psychiatric / Neuropsychiatric207%
Respiratory196%
Cardiac / Cardiovascular155%
Allergic / Anaphylactic155%
Musculoskeletal103%
Thrombotic / Hematological31%

Where reports came from

U.S. state of the reporter, where given (top 12).

California54
Texas21
Kansas17
Oregon12
Montana11
Pennsylvania10
Florida8
Nebraska4
Louisiana4
Wisconsin3
Minnesota3
Utah3

Reports by month received

2022-0616
2022-0785
2022-0819
2022-0929
2022-1011
2022-113
2022-1213
2023-012
2023-021
2023-041
2023-071
2023-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.